Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 110

Results For "ENT"

9323 News Found

CureVac highlights shift to mRNA technology in seasonal influenza vaccine development: GlobalData
Clinical Trials | September 19, 2023

CureVac highlights shift to mRNA technology in seasonal influenza vaccine development: GlobalData

CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology


CAHO and PFPSF launch Patient Advisory Councils
Healthcare | September 18, 2023

CAHO and PFPSF launch Patient Advisory Councils

Patient Advisory Councils (PACs) to be set up across hospitals to make patients true partners in enhancing patient safety and improving care delivery


Merck receives positive EU CHMP opinion for Keytruda as adjuvant treatment for  cell lung cancer
Drug Approval | September 18, 2023

Merck receives positive EU CHMP opinion for Keytruda as adjuvant treatment for cell lung cancer

Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial


Minister Gadkari inaugurates the Robotic Urology Centre at UroKul, Pune
News | September 16, 2023

Minister Gadkari inaugurates the Robotic Urology Centre at UroKul, Pune

UroKul, Pune is the largest centre to conduct reconstructive urology surgery outside USA and UK


Strides receives tentative USFDA approval for Dolutegravir/Lamivudine/Tenofovir Disproxil Fumurate tablets
Drug Approval | September 16, 2023

Strides receives tentative USFDA approval for Dolutegravir/Lamivudine/Tenofovir Disproxil Fumurate tablets

Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa


Narayana Health unveils new brand identity
News | September 15, 2023

Narayana Health unveils new brand identity

The new logo incorporates three beating hearts seamlessly & reinforces 'healthcare with a heart' into the Group's visual identity


Strides receives tentative USFDA approval for Dolutegravir tablets
Drug Approval | September 15, 2023

Strides receives tentative USFDA approval for Dolutegravir tablets

The products will be manufactured at the company's facility in Bengaluru


Sun Pharma and Pharmazz ink agreement for introducing Tyvalzi in India
News | September 15, 2023

Sun Pharma and Pharmazz ink agreement for introducing Tyvalzi in India

Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)


SMi Systems secures UK patent for breakthrough single molecule imaging capabilities
Medical Device | September 15, 2023

SMi Systems secures UK patent for breakthrough single molecule imaging capabilities

The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics


Celanese inks agreement with the Population Council to supply its VitalDose drug delivery platform
News | September 14, 2023

Celanese inks agreement with the Population Council to supply its VitalDose drug delivery platform

The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades